E-drug: DIA Drug Safety Meeting - South Africa
----------------------------------------------------------
Annoncement:
Drug Information Association Meeting
"DRUG SAFETY: A SHARED RESPONSIBILITY"
August 30, 31 and 1 September, 1999
Eskom Conference Centre, Gauteng, South Africa
30 August : Special Meeting for African Drug Regulatory Officials
31 August - 1 September: Open Meeting
A comprehensive update on.....
a) the new regulations on adverse drug reaction reporting in South
Africa.
b) developing post-marketing surveillance systems for drugs, and the
strengths and weaknesses of the systems currently used.
c) concepts of signals detection and analysis, and communication
of risk benefit information to prescribers, policy makers and the
media.
d) developing an efficient system for handling product
quality problems
e) the importance of drug safety monitoring in the
Sub-Saharan African region and the role and
responsibilities of the various players in promoting the safe use of
medicines.
f) the specific drug safety problems facing the Sub-Saharan African
region and formulating a research and policy agenda which will
address these problems.
Who Should Attend?
i) Members of the pharmaceutical industry
ii) Members of Drug Regulatory Authorities in the Sub-Saharan African
region;
iii) Faculty members and students from pharmacy and pharmacology
departments with an interest in drug safety; and
iv) Any person keen to share the responsibility for monitoring
drug safety.
Registration fees
Government and Academia ZAR 1000 ($ 165)
Private sector ZAR 2 900 ($ 465)
*Discount of $65 is given to DIA members
*Group Discount available - send 3, the 4th attends for free.
For further information and registration forms please contact
Thembi Dike (tdike@uctgsh1.uct.ac.za) or
Kris Curry (CURRY@diahome.org)
PROGRAMME
Tuesday 31 August 1999
Morning Session Chairperson:
Professor Peter Folb
University of Cape Town
09:00 Drug Safety: A Shared Responsibility
Dr Helen Rees
Chairperson: Medicines Control Council
10:00 A Critical look at Post-marketing surveillance
Dr Win Castle
Smith Kline Beecham, USA
11:20 The Early Detection of Safety Signals
Professor Ralph Edwards
Uppsala Monitoring Centre, Sweden
12:30 How can we improve the value of Post Marketing Surveillance?
Plenary Discussion
Facilitator: Dr Win Castle
Afternoon Session Chair
Dr Helen Rees
Chairperson: Medicines Control Council
14:30 Promoting Drug Safety: A shared responsibility
Speakers:
Prof Indres Moodley - Wits Univiersity
Dr John Straughan - Warner Lambert
Mrs Gugu Mahlangu - Medicines Control Authority, Zimbabwe
Mr Rene Doms - Pharma Natura, SA
16:00 Improving the performance of the role
players:
Plenary discussion
Dr Karen Barnes (Facilitator)
University of Cape Town
Wednesday, 1 September, 1999
Morning Session Chairperson:
Dr Win Castle
SmithKline Beecham, USA
09:00 Reporting requirements for the Pharmaceutical Industry in
South Africa
Dr Ushma Mehta
National Adverse Drug Event Monitoring centre, MCC, SA
10:50 Dealing with Product Quality Problems
Mr Seemole Mohoto -MCC
Dr Chris Stubbs - Pharmacare SA
12:00 Communication of Risk
Professor Ralph Edwards
Uppsala Monitoring Centre, Sweden
Afternoon Session Chair
Professor Ralph Edwards
Uppsala Monitoring Centre, Sweden
14:30 Identifying Priorities for Drug Safety Africa
Mrs Precious Matsoso - Registrar of Medicines, SA
Dr Konji Sebati - Pfizer, SA
Dr Wilbert Bannenberg - SA Drug Action Programme
Prof. Norman Nyazema - Head of Pharmacology, University of Zimbabwe,
Zimbabwe
16:30 Identifying Priorities for Drug Safety Africa
Panel Disucssion
Facilitator: Prof Ralph Edwards
Uppsala Monitoring Centre, Sweden